Students of the year 2007


  1. Rakesh Bakshi INDIA 
    supervisor: PD Dr. H. Wedemeyer, Gastroenterology, Hepatology & Endocrinology, OE 6810,  
    project: Role of heterologous immunity for natural resistance to HCV infection
    Final exam June 2011. from 2013 Postdoc, from 2016 scientist I, Microbiology, University of Alabama, Birmingham, United States; from 2018 Senior Scientist and Junior Group Leader, Division of Infectious Diseases, University of Alabama, Birmingham, USA, sadly passed away in June 2019

  2. Vijay Kumar Chennupati INDIA 
    supervisor: Dr. Prinz, Immunology, OE 5240,   
    project:  gd T lymphocyte migration, homing and site-specific function
    Final exam November 2010; Ludwig Institute for Cancer Research, Lausanne, Switzerland; now principal investigator, Syngene International Ltd., Bangalore, India

  3. Sheetal Chettiar INDIA  
    supervisor: Dr. Tamura-Niemann, Physiological Chemistry, OE 4310,    
    project: Characterization of the PEST domain of Fms interacting protein/FMIP and DNA damage signaling
    Final exam November 2011. University of Kerala as Lecturer for Master program Integrative Biology course; R&D Farmington, Michigan, USA; now babypause

  4. Sadaf Kasraie IRAN 
    supervisor: Prof. Dr. Werfel, Dermatology, OE 6600,  
    project: Dysregulation of innate and adaptive immunity in patients with atopic dermatitis: Impact of Toll-like receptors and β-defensins
    Final exam November 2010; scientist and scientific project manager, Global Preclinical R&D, Global Drug Discovery, Grünenthal Pharma GmbH, Aachen, Germany; from 2014 Evotec, drug discovery in Inflammation, Hamburg; from 2017 senior project manager, The Aptuit Center for Drug Discovery & Development, Verona, Italy

  5. Katja Crull (nee Kochrübe) GERMANY  
    supervisor: Prof. Dr. Weiss, Helmholtz Center for Infection Research, Braunschweig;
    project:  Identification of tumour-specific promoters of E. coli NISSLE
    Final exam June 2011; from 2/2012-2016: Wehrwissenschaftl. Institut, Bereich Biologisches Zentrallabor, Munster; from 2017 Project manager in Agilen surrounding, Volkswagen Group IT Services GmbH, Wolfsburg

  6. Daniel Kotlarz  GERMANY 
    supervisor: Prof. Dr. Klein, Pediatric Hematology and Oncology, OE 6780,
    project: The role of the cellular adaptor protein p14 in hematopoiesis and leukemia.
    Final exam November 2014; Klinikum d. Universität München, Kinder- und Kinderpoliklinik im Dr. von Haunerschen Kinderspital

  7. Jayendra Kumar Krishnaswamy INDIA  
    supervisor:  Prof. Dr. Behrens, Clinical Immunology, OE 6830,   
    project: Antigenic targeting of dendritic cell subsets for tolerance induction to inhaled antigens
    Final exam November 2011; Yale University School of Medicine, USA; Senior Research Bioscientist, AstraZeneca, RIA iMED, Gothenburg, Sweden; now Principal Scientist, Nestle Skin Health/ Galderma, Switzerland

  8. Jan Larmann  ( GERMANY  
    supervisor: Prof. Dr. Theilmeier, Anaestesiology, OE 8050,   
    project: Afterload-induced changes in myocardial transcription driven by thrombomodulin’s lectin-like domain
    Final exam November 2010; Anaestesiology, MHH; now senior physician, “Oberarzt” and group leader, Anesthesiology, university hospital Heidelberg

  9. Subhashree Mahapatra INDIA  
    supervisor: Dr. Dittrich,  SFB 587, OE 9431,
    project:  Polysensitization & skin lung interplay in a mouse model of allergic skin inflammation
    Final exam November 2012; Advanced research scientist, L'Oreal, Paris; from 2016 Business Development Manager, Lubrizol, Barcelona

  10. Ankita Minhas INDIA   
    supervisor: Prof. Dr. Klein, Pediatric Hematology and Oncology, OE 6780, 
    project: The use of morpholino based knockdown gene technology as well as genetic studies  to determine the function of HAX1 in zebrafish
    Final exam November 2011; Project Manager, Vakzine Project Management GmbH, Hannover; from 2014 Project ManagerII with a global CRO INC Research LLC., San Diego, USA, from 2016 project director at Syneos Health in Munich; now director, Project Management at ICON Plc

  11. Susann Hartung (nee Müller) GERMANY 
    supervisor: Dr. Martin, LEBAO, OE 6217,
    project: Identification of cardiogenic factors in a Rhesus monkey embryonic stem cell model
    Final exam November 2012; LEBAO MHH; from September 2013 Babypause; University Hospital Jena; now Infections in Hematology and Oncology, Leibniz Institute for Natural Product Research and Infection Biology, Hans Knöll Institute (HKI), Jena

  12. Mudita Pincha INDIA 
    supervisor: PD Dr. Stripecke, Hematology and Oncology, OE 6860, 
    project: Lentivirus programmed dendritic cells for immunotherapy of melanoma
    Final exam November 2011, German Cancer Research Center (DKFZ), Heidelberg; from 2016 scientist, Pharma Research and Early Development (pRED), Roche Innovation Center, Zürich, Switzerland

  13. Thanaseelan Pushpanathan MALAYSIA    
    supervisor: Dr. Ehlers/Dr. Reinhardt, Pediatric Hematology and Oncology, OE 6780,
    project: Expression of the G-CSF receptor isoform IV and consecutive changes in the intracellular signal transduction in childhood acute myeloid leukemia

  14. Harald Schütt ( GERMANY
    superrvisor: Prof. Dr. Schieffer, Cardiology, OE 6880,    
    project: Investigation of cytokine signalling mechanisms in the course of atherosclerosis
    Final exam November 2010; Cardiology, MHH; from 2013 Cardiology, University Clinics Marburg

  15. Adrian Schwarzer ( GERMANY
    supervisor: Prof. Dr. Baum, Experimental Hematology, OE 6960,
    project: 1.Molecular characterization of mouse models of leukemia; 2.Mechanisms of induction of immunologic tolerance by leukemic cells; 3.Gene therapy for hematologic disorders
    Final exam November 2012; Haematology and Oncology, MHH (junior group leader) and physician

  16. Theodros Solomon Tsegaye  (MD) ETHIOPIA 
    supervisor: Prof. Dr. Pöhlmann, Virology, OE 5230,
    project: HIV interaction with platelets: the role of CLEC- 2 and DC-SIGN receptors
    Final exam June 2011; Postdoctoral Fellowship at the Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA 2011-2013; US Medical Residency Studies 2014-2016; Internal Medicine Residency at East Carolina University, Greenville, NC USA 2016-2019; Internal Medicine/Hospital Medicine Specialist in Midwest USA 2019-Present

  17. Usriansyah INDONESIA 
    supervisor: PD Dr. O. Pabst, Immunology, OE 5240,
    project: The structural, cellular and molecualr basis of intestinal tolerance
    Final exam June 2011; Dermatology, University Hospital Zuerich, Switzerland; now Market Manager, Mettler-Toledo, Urdorf, Switzerland

  18. Susanne Wolf GERMANY 
    supervisor: Dr. C. Rudolph/Prof. Schlegelberger, Cell-/ Molecular Pathology, OE 5120,  
    project: Synergistic effects of histone methylation defects and oncogene activation and their contribution to the induction of chromosomal instability in leukemogenesis
    Final exam November 2011; Haematology and Oncology, MHH